CD274 and neoplasm: To further investigate the effect of BJIKT in the tumor immune system, we built two subcutaneous syngeneic models in immunocompetent MC38-bearing mice and poorly immunogenic LLC1-bearing mice and investigated the combinatorial effect of 1.0 g/kg BJIKT with anti-PD-L1 antibody on tumor growth and weight in vivo.